Micafungin Side Effects: What to Expect and When to Call Your Doctor

Micafungin (brand name Mycamine) is an echinocandin antifungal administered by IV infusion. Compared to older antifungal agents like amphotericin B, micafungin is generally considered well-tolerated with a favorable safety profile. However, like all medications, it can cause side effects, and some are serious enough to require immediate medical attention. This guide covers what patients and caregivers need to know.

Common Side Effects of Micafungin

The following side effects are the most frequently reported with micafungin and are typically mild to moderate in severity:

Nausea — One of the most common GI complaints; usually mild

Diarrhea — Gastrointestinal upset is reported frequently

Vomiting

Fever (pyrexia) — Can be an infusion-related reaction or a sign of infection; notify your doctor if fever develops during treatment

Headache

Elevated liver enzymes (transaminases) — Detected through lab testing; usually resolves after stopping the medication

Thrombocytopenia — A decrease in platelet count; detected via lab monitoring

Rash, pruritus (itching), and flushing — Histamine-like reactions that can occur, especially if the infusion runs too quickly

Infusion-Related Reactions

Micafungin is infused over approximately one hour. Infusing it too quickly can increase the risk of histamine-mediated reactions including rash, pruritus (itching), facial swelling, flushing, and vasodilation. If you experience any of these symptoms during your infusion, tell your nurse or healthcare provider immediately. The infusion rate may need to be slowed. It is not necessary to cover the IV bag or tubing from light.

Serious Side Effects: When to Call Your Doctor Immediately

While rare, micafungin can cause serious adverse reactions. Seek emergency care or call your doctor immediately if you experience any of the following:

Severe Allergic Reactions (Anaphylaxis)

Isolated cases of anaphylaxis and anaphylactoid reactions, including shock, have been reported with micafungin. Symptoms include sudden difficulty breathing, throat tightening, severe drop in blood pressure, rapid heartbeat, and loss of consciousness. If the infusion is running, stop it immediately and call emergency services.

Hemolytic Anemia and Blood Disorders

Cases of acute intravascular hemolysis (destruction of red blood cells within blood vessels), hemolytic anemia, and hemoglobinuria have been reported. Symptoms include unusual fatigue, pale or yellow skin (jaundice), dark or reddish-brown urine, and rapid heart rate. Notify your doctor immediately if your urine appears red or brown during micafungin treatment.

Liver Damage (Hepatotoxicity)

Liver enzyme elevations are common and usually mild. However, clinically significant liver damage can occur. Warning signs include yellowing of the skin or eyes (jaundice), dark urine, severe upper right abdominal pain, extreme fatigue, and loss of appetite. Keep all scheduled lab appointments during micafungin therapy, as liver function tests should be monitored regularly.

Kidney Damage

Kidney damage can occur with micafungin. Symptoms include decreased urination, swelling in the legs, ankles, or feet, and extreme fatigue. Kidney function tests (creatinine and BUN) should be monitored during therapy. Unlike amphotericin B, micafungin is significantly less nephrotoxic and does not require dose adjustment for renal impairment.

A Note on Long-Term Safety: Liver Tumors in Rats

In long-term animal studies, micafungin caused liver damage and subsequent liver tumors in rats. The clinical significance of this finding for humans is not established, and micafungin has been used in hundreds of thousands of patients without a documented increase in liver tumor incidence. Your doctor will weigh the benefits and risks of micafungin therapy before initiating treatment. The typical treatment course for most indications is 14 to 21 days, which is substantially shorter than the duration of exposure in animal carcinogenicity studies.

Lab Monitoring During Micafungin Therapy

To catch side effects early, your doctor will likely order regular laboratory tests during your micafungin course. These typically include: liver function tests (AST, ALT, alkaline phosphatase, bilirubin), complete blood count (to monitor for thrombocytopenia and hemolytic anemia), kidney function tests (creatinine, BUN), and repeat blood cultures to confirm clearance of the fungal infection.

Micafungin Safety During Pregnancy and Breastfeeding

Animal studies have shown that micafungin crosses the placental barrier and may have reproductive toxicity. There are no adequate human studies in pregnant women. Micafungin should only be used during pregnancy if clearly necessary, with the benefits carefully weighed against the risks. It is not known whether micafungin is excreted in human breast milk. Discuss with your doctor if you are pregnant or breastfeeding before starting micafungin.

For information about medication interactions that could affect your safety on micafungin, read our article on micafungin drug interactions: what to avoid and what to tell your doctor.